Qualigen Therapeutics has released a pre-launch supply of its proposed FastPack® SARS-CoV-2 IgG Immunoassay diagnostic test kits to the University of Louisville. Read more...
Clinical Ink has helped expedite the study of a treatment for cytokine storm, the immunological reaction associated with severe cases of COVID-19. Read more...
Cellenkos announced the FDA has cleared the way to initiate a trial of CK0802 for COVID-19 associated acute respiratory distress syndrome (ARDS). Read more...